EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neonicotinoids and Mental Health: Mechanistic, Preclinical and Epidemiological Evidence for a Transdiagnostic Neurodevelopmental Risk

Gilberto Uriel Rosas-Sánchez, Cesar Soria-Fregozo, Ena Hazel Ortíz-Sánchez, Santiago Avalos-García, Juan Francisco Rodríguez-Landa, León Jesús Germán-Ponciano, Silvia Lizette Ramos de Robles, Mario Eduardo Flores-Soto, Rafael Fernández-Demeneghi, María Isabel Pérez-Vega, Alejandro David Soriano-Hernández

Toxics · 19.11.2026 · 14 (11) · 1026

DOI: 10.3390/toxics14111026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxics, online erschienen am 19.11.2026. Verfasst von Gilberto Uriel Rosas-Sánchez und 10 weiteren Autor:innen. Die Arbeit nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neonicotinoid insecticides (imidacloprid, clothianidin, thiacloprid, acetamiprid, thiamethoxam, nitenpyram, dinotefuran) were developed as insect-selective nicotinic acetylcholine receptor (nAChR) agonists and have long been regarded as safe for vertebrates. However, parent compounds and, more potently, desnitro metabolites such as DN-imidacloprid act on mammalian α4β2 and α7 nAChRs with nicotine-like potency, implicating cholinergic circuits central to cognition, mood, and reward. This narrative review synthesizes mechanistic, preclinical, and epidemiological evidence linking neonicotinoid exposure to neuropsychiatric risk. Mechanistically, these compounds promote glial activation, oxidative stress, blood–brain barrier (BBB) disruption, and gut microbiota alterations that converge on hippocampal and limbic dysfunction. Rodent and invertebrate studies show sex-, dose-, and exposure-window-dependent effects on anxiety-, depression-, and cognition-like behaviors, with developmental exposure mirroring prenatal nicotine effects. Human data, although limited, are convergent: poisoning case series document acute neuropsychiatric symptoms; biomonitoring studies in China, Japan, and Sri Lanka associate urinary metabolites with depression, anxiety, and a recognizable “neo-nicotinic” symptom cluster; in Mexico, studies of agricultural populations link pesticide mixtures to psychological distress, although neonicotinoid biomarkers have not yet been measured in that setting; and pediatric cohorts in China and Ecuador link prenatal and childhood exposure to impaired neurodevelopment, emotional symptoms, and hyperactivity. Collectively, this evidence is consistent with neonicotinoids being an underrecognized environmental risk factor for neuropsychiatric disorders, although the human data remain too fragmented to support causal inference and underscores the need for dedicated cohorts, expanded biomonitoring, and mechanistic research to inform regulatory assessment.

Zitieren

APA

Rosas-Sánchez, G. U., Soria-Fregozo, C., Ortíz-Sánchez, E. H., Avalos-García, S., Rodríguez-Landa, J. F., Germán-Ponciano, L. J., Robles, S. L. R. D., Flores-Soto, M. E., Fernández-Demeneghi, R., Pérez-Vega, M. I., & Soriano-Hernández, A. D. (2026). Neonicotinoids and Mental Health: Mechanistic, Preclinical and Epidemiological Evidence for a Transdiagnostic Neurodevelopmental Risk. Toxics, 14(11), 1026. https://doi.org/10.3390/toxics14111026

Vancouver

Rosas-Sánchez GU, Soria-Fregozo C, Ortíz-Sánchez EH, Avalos-García S, Rodríguez-Landa JF, Germán-Ponciano LJ, et al. Neonicotinoids and Mental Health: Mechanistic, Preclinical and Epidemiological Evidence for a Transdiagnostic Neurodevelopmental Risk. Toxics. 2026;14(11):1026. doi:10.3390/toxics14111026

BibTeX
@article{RosasSnchez2026,
  author = {Rosas-Sánchez, Gilberto Uriel and Soria-Fregozo, Cesar and Ortíz-Sánchez, Ena Hazel and Avalos-García, Santiago and Rodríguez-Landa, Juan Francisco and Germán-Ponciano, León Jesús and Robles, Silvia Lizette Ramos de and Flores-Soto, Mario Eduardo and Fernández-Demeneghi, Rafael and Pérez-Vega, María Isabel and Soriano-Hernández, Alejandro David},
  title = {Neonicotinoids and Mental Health: Mechanistic, Preclinical and Epidemiological Evidence for a Transdiagnostic Neurodevelopmental Risk},
  journal = {Toxics},
  year = {2026},
  volume = {14},
  number = {11},
  pages = {1026},
  doi = {10.3390/toxics14111026}
}
Kostenlos starten →